Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD in Brazilian Jiu-Jitsu Athletes
NCT07552974Phase 3Not yet recruiting
- Sponsor
- APAME
- Start
- Jan 2027
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delayed onset muscle soreness (DOMS), sleep disorders and inflammation comparing CBD 100mg BID with Placebo BID (2 arms). Primary endpoint: Serum levels of pro-inflammatory and anti-inflammatory cytokines at 12 weeks. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
delayed onset muscle soreness (DOMS)sleep disordersinflammation
Beyond the preview
Go deeper on NCT07552974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07552974.